SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Beverley J. Hunt, Shubha Allard, David Keeling, Derek Norfolk, Simon J. Stanworth, Kate Pendry, A practical guideline for the haematological management of major haemorrhage, British Journal of Haematology, 2015, 170, 3
  2. 2
    Áron Altorjay, Éva Szabó, Zoltán Boda, Ludwig Kramer, Leock Y. Ngo, Werner Engl, Clair L. Firth, Erik R. Ahlstrom, David M. Gelmont, Ingrid Pabinger, An international, multicenter, prospective study of a prothrombin complex concentrate, Prothromplex Total®, in anticoagulant reversal, Thrombosis Research, 2015, 135, 3, 485

    CrossRef

  3. 3
    Michèle Kessler, Frédérique Moureau, Philippe Nguyen, Anticoagulation in Chronic Hemodialysis: Progress Toward an Optimal Approach, Seminars in Dialysis, 2015, 28, 4
  4. 4
    S. A. Black, A. T. Cohen, Anticoagulation strategies for venous thromboembolism: moving towards a personalised approach, Thrombosis and Haemostasis, 2015, 114, 3

    CrossRef

  5. 5
    C. Sticherling, F. Marin, D. Birnie, G. Boriani, H. Calkins, G.-A. Dan, M. Gulizia, S. Halvorsen, G. Hindricks, K.-H. Kuck, A. Moya, T. Potpara, V. Roldan, R. Tilz, G. Y. H. Lip, B. Gorenek, J. H. Indik, P. Kirchhof, C.-S. Ma, C. Narasimhan, J. Piccini, A. Sarkozy, D. Shah, I. Savelieva, Antithrombotic management in patients undergoing electrophysiological procedures: a European Heart Rhythm Association (EHRA) position document endorsed by the ESC Working Group Thrombosis, Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Society (APHRS), Europace, 2015,

    CrossRef

  6. 6
    F. Shabani, A. J. Farrier, R. Krishnaiyan, C. Hunt, C. E. Uzoigwe, M. Venkatesan, Common contra-indications and interactions of drugs in orthopaedic practice, The Bone & Joint Journal, 2015, 97-B, 4, 434

    CrossRef

  7. 7
    Herm Brinkman, Global assays and the management of oral anticoagulation, Thrombosis Journal, 2015, 13, 1, 9

    CrossRef

  8. 8
    Franco Radaelli, Francesco Dentali, Alessandro Repici, Arnaldo Amato, Silvia Paggi, Emanuele Rondonotti, Jean Marc Dumonceau, Management of anticoagulation in patients with acute gastrointestinal bleeding, Digestive and Liver Disease, 2015, 47, 8, 621

    CrossRef

  9. 9
    J. J. Veen, M. Makris, Management of peri-operative anti-thrombotic therapy, Anaesthesia, 2015, 70,
  10. 10
    Courtney A. Lyle, Robert F. Sidonio, Neil A. Goldenberg, New developments in pediatric venous thromboembolism and anticoagulation, including the target-specific oral anticoagulants, Current Opinion in Pediatrics, 2015, 1

    CrossRef

  11. 11
    George Kimpton, Bassam Dabbous, Paul Leach, New oral anticoagulant and antiplatelet agents for neurosurgeons, British Journal of Neurosurgery, 2015, 1

    CrossRef

  12. 12
    J. I. Weitz, C. V. Pollack, Practical management of bleeding in patients receiving non-vitamin K antagonist oral anticoagulants, Thrombosis and Haemostasis, 2015, 114, 5

    CrossRef

  13. 13
    Sean Yates, Ravi Sarode, Reversal of Anticoagulant Effects in Patients with Intracerebral Hemorrhage, Current Neurology and Neuroscience Reports, 2015, 15, 1

    CrossRef

  14. 14
    David Faraoni, Jerrold H Levy, Pierre Albaladejo, Charles-Marc Samama, Updates in the perioperative and emergency management of non-vitamin K antagonist oral anticoagulants, Critical Care, 2015, 19, 1

    CrossRef

  15. 15
    Georg Breuer, Dominik R. Weiss, Juergen Ringwald, ‘New’ direct oral anticoagulants in the perioperative setting, Current Opinion in Anaesthesiology, 2014, 27, 4, 409

    CrossRef

  16. 16
    H.M. Hirri, P.J. Green, Audit of warfarin reversal using a new Octaplex reduced dose protocol, Transfusion and Apheresis Science, 2014, 51, 2, 141

    CrossRef

  17. 17
    Beverley J. Hunt, Bleeding and Coagulopathies in Critical Care, New England Journal of Medicine, 2014, 370, 9, 847

    CrossRef

  18. 18
    Peter P. Toth, Direct oral anticoagulants as alternative treatment options for the effective long-term treatment of patients with pulmonary embolism in primary care: a review, Annals of Medicine, 2014, 46, 6, 341

    CrossRef

  19. 19
    Sacha Solbeck, Martin A.S. Meyer, Pär.I. Johansson, Anna Sina P. Meyer, Bryan A. Cotton, Jakob Stensballe, Ulf Schött, Sisse R. Ostrowski, Monitoring of dabigatran anticoagulation and its reversal in vitro by thrombelastography, International Journal of Cardiology, 2014, 176, 3, 794

    CrossRef

  20. 20
    S. Haas, S. Schellong, Neue orale direkte Antikoagulanzien, Der Internist, 2014, 55, 5, 537

    CrossRef

  21. 21
    Neville M. Gibbs, William M. Weightman, Stephen A. Watts, New antithrombotic agents in the ambulatory setting, Current Opinion in Anaesthesiology, 2014, 27, 6, 589

    CrossRef

  22. You have free access to this content22
    H. Tran, J. Joseph, L. Young, S. McRae, J. Curnow, H. Nandurkar, P. Wood, C. McLintock, New oral anticoagulants: a practical guide on prescription, laboratory testing and peri-procedural/bleeding management, Internal Medicine Journal, 2014, 44, 6
  23. 23
    Samuel Lévy, Newer clinically available antithrombotics and their antidotes, Journal of Interventional Cardiac Electrophysiology, 2014, 40, 3, 269

    CrossRef

  24. 24
    Helen Mani, Natalie Herth, Alexander Kasper, Thomas Wendt, Gundolf Schuettfort, Yvonne Weil, Waltraud Pfeilschifter, Birgit Linnemann, Eva Herrmann, Edelgard Lindhoff-Last, Point-of-Care Coagulation Testing for Assessment of the Pharmacodynamic Anticoagulant Effect of Direct Oral Anticoagulant, Therapeutic Drug Monitoring, 2014, 36, 5, 624

    CrossRef

  25. 25
    M. Makris, Prothrombin complex concentrate for non-vitamin K oral anticoagulant reversal: good enough for now?, Journal of Thrombosis and Haemostasis, 2014, 12, 9
  26. 26
    J. Thachil, The newer direct oral anticoagulants: a practical guide, Clinical Medicine, 2014, 14, 2, 165

    CrossRef

  27. 27
    K. T. Htun, J. McFadyen, H. A. Tran, The successful management of dabigatran-associated critical end-organ bleeding with recombinant factor VIIa, Annals of Hematology, 2014, 93, 10, 1785

    CrossRef

  28. 28
    Serena Valsami, Lars M. Asmis, A Brief Review of 50 Years of Perioperative Thrombosis and Hemostasis Management, Seminars in Hematology, 2013, 50, 2, 79

    CrossRef

  29. 29
    C.F. Weber, K. Zacharowski, K. Brün, T. Volk, E.O. Martin, S. Hofer, S. Kreuer, Basisalgorithmus für „Point-of-Care“ basierte Hämotherapie, Der Anaesthesist, 2013, 62, 6, 464

    CrossRef

  30. 30
    David Keeling, Raza Alikhan, Management of venous thromboembolism – controversies and the future, British Journal of Haematology, 2013, 161, 6
  31. 31
    S. Shapiro, M. Laffan, New oral anticoagulants: their role and future, Clinical Medicine, 2013, 13, Suppl_6, s53

    CrossRef

  32. 32
    Jecko Thachil, Gill Pike, Lynne Keighley-Jones, Michael J. Nash, Plasma Dabigatran Activity One Week After Discontinuation Despite Normal Renal Function, The American Journal of Medicine, 2013, 126, 8, e5

    CrossRef

  33. 33
    C. Woodhouse, G. Evans, A. F. Muller, The new oral anticoagulants: practical management for patients attending for endoscopic procedures, Frontline Gastroenterology, 2013, 4, 3, 213

    CrossRef

  34. 34
    Deepa Jayakody Arachchillage, Hannah Cohen, Use of New Oral Anticoagulants in Antiphospholipid Syndrome, Current Rheumatology Reports, 2013, 15, 6

    CrossRef

  35. 35
    Joost J. van Veen, Reversal and Monitoring of Anticoagulants,